Dental procedures may lead to bleeding in VWD, hemophilia
People with von Willebrand disease (VWD) or hemophilia may experience bleeding complications after dental procedures, a new study highlights. Bleeding after such procedures, notably…
News
Doptelet, Doptelet Sprinkle for pediatric ITP win FDA approval
Sobi’s Doptelet (avatrombopag), which is available as a tablet and an oral granule called Doptelet Sprinkle, is now approved in the U.S. for children…
Hormonal therapy does not seem to lighten heavy periods in VWD
Hormonal therapy may not be as effective as previously believed to control heavy menstrual bleeding in women with type 1 von Willebrand disease (VWD),…
Diagnosing, treating TTP promptly improves pregnancy outcomes
Acquired thrombotic thrombocytopenic purpura (TTP) during pregnancy must be distinguished from other conditions, monitored carefully, and treated promptly to ensure the best possible outcomes…
Gut bacteria types may influence ITP progression in children: Study
Children and adolescents newly diagnosed with immune thrombocytopenia (ITP) show clear differences in gut microbiota — the community of bacteria and other microbes living…
Doptelet found safe, effective in previously treated children with ITP
Doptelet (avatrombopag) was safe and effective in children with immune thrombocytopenia (ITP) who had an insufficient response to previous treatments, according to recently…
Hetrombopag is safe, effective for ITP in real-world settings: Study
Hetrombopag appears to be a safe and effective option in real-world settings for immune thrombocytopenia (ITP), with better outcomes linked with a higher starting…
